Feb 25, 2021 09:00AM

Dec 21, 2020 01:15AM

Oct 14, 2020 01:15AM

Sep 14, 2020 06:09AM

Sep 14, 2020 01:15AM

Sep 14, 2020 01:15AM

Aug 31, 2020 08:53AM Pre-Open Stock Movers 8/31: (AIMT) (AKCA) (GNW) (ACST) (LPCN) (BIGC) (More...)

Aug 31, 2020 06:04AM

Aug 31, 2020 01:15AM

Aug 31, 2020 01:15AM

Aug 24, 2020 08:30AM

Aug 7, 2020 08:00AM

Jul 30, 2020 04:05PM

Jul 23, 2020 08:30AM Aimmune Therapeutics to Host Conference Call and Webcast to Discuss Second Quarter 2020 Financial Results and Recent Operational Highlights

Jul 21, 2020 08:32AM

Jul 21, 2020 08:30AM

Jul 6, 2020 08:30AM

Jul 1, 2020 07:23AM

Jun 8, 2020 08:05AM

Jun 8, 2020 08:00AM

Jun 8, 2020 08:00AM New Two-Year PALFORZIA™ Data Show On-going Safety and Efficacy and Continued Immunomodulation in Patients with Peanut Allergy

Jun 4, 2020 08:00AM

Jun 1, 2020 08:00AM

May 28, 2020 07:30AM

May 12, 2020 08:00AM

May 11, 2020 04:05PM

Apr 30, 2020 08:00AM

Apr 8, 2020 08:00AM Aimmune Therapeutics to Present at the 19th Annual Needham Virtual Healthcare Conference

Mar 16, 2020 08:00AM

Mar 13, 2020 05:00PM

Feb 27, 2020 04:24PM

Feb 27, 2020 04:05PM

Feb 26, 2020 08:00AM

Feb 25, 2020 08:00AM

Feb 20, 2020 08:30AM Aimmune Therapeutics to Host Conference Call and Webcast to Discuss Fourth Quarter and Full-Year 2019 Financial Results and Recent Operational Highlights

Feb 5, 2020 08:58AM

Feb 5, 2020 08:08AM

Feb 5, 2020 08:06AM

Feb 5, 2020 08:01AM

Feb 3, 2020 09:23AM

Feb 3, 2020 06:58AM

Jan 31, 2020 05:04PM FDA Approves Aimmune’s PALFORZIA™ as First Treatment for Peanut Allergy

Jan 6, 2020 08:30AM

Nov 15, 2019 04:05PM

Nov 8, 2019 11:00AM

Nov 8, 2019 11:00AM

Nov 8, 2019 07:16AM

Nov 8, 2019 07:00AM

Nov 8, 2019 07:00AM AR101 Demonstrates Consistent Efficacy and Safety in New Analysis at ACAAI Comparing PALISADE and ARTEMIS Phase 3 Clinical Data

Nov 6, 2019 05:10PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All